Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-24
DOI
10.1038/s41598-017-09520-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer
- (2016) Bo Zhang et al. BIOMATERIALS
- Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice
- (2016) Bo Zhang et al. BIOMATERIALS
- Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor
- (2016) Bo Zhang et al. BIOMATERIALS
- Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia
- (2015) Manli Song et al. ACS Nano
- UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma
- (2015) Bo Zhang et al. BIOMATERIALS
- A Novel Combined Micellar System of Lapatinib and Paclitaxel with Enhanced Antineoplastic Effect Against Human Epidermal Growth Factor Receptor-2 Positive Breast Tumor In Vitro
- (2015) Yan Wei et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
- (2015) Yiyao Zhang et al. Oncotarget
- Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
- (2015) Tian-Huei Chu et al. Oncotarget
- Inhibition of COX-2 in Colon Cancer Modulates Tumor Growth and MDR-1 Expression to Enhance Tumor Regression in Therapy-Refractory Cancers In Vivo
- (2015) Mahbuba Rahman et al. NEOPLASIA
- Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
- (2014) Shutao Guo et al. ACS Nano
- Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
- (2014) Bo Zhang et al. BIOMATERIALS
- Tumor Vessel Normalization by Chloroquine Independent of Autophagy
- (2014) Hannelore Maes et al. CANCER CELL
- Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation
- (2014) Hailiang Wu et al. JOURNAL OF CONTROLLED RELEASE
- Progress of drug-loaded polymeric micelles into clinical studies
- (2014) Horacio Cabral et al. JOURNAL OF CONTROLLED RELEASE
- LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
- (2013) Bo Zhang et al. BIOMATERIALS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Strategies for advancing cancer nanomedicine
- (2013) Vikash P. Chauhan et al. NATURE MATERIALS
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Photoswitchable nanoparticles for in vivo cancer chemotherapy
- (2013) R. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- A tissue factor targeted nanomedical system for thrombi-specific drug delivery
- (2012) Wei Shi et al. BIOMATERIALS
- Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer
- (2012) A. Kirane et al. CLINICAL CANCER RESEARCH
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
- (2012) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-targeted TNF stabilizes tumor vessels and enhances active immunotherapy
- (2012) A. Johansson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer
- (2011) P. Venkatesan et al. BIOMATERIALS
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
- (2011) Y. Nakanishi et al. CARCINOGENESIS
- Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells
- (2011) Cyril Sobolewski et al. CELL CYCLE
- Effect of celecoxib on proliferation, collagen expression, ERK1/2 and SMAD2/3 phosphorylation in NIH/3T3 fibroblasts
- (2011) Fengfeng Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells
- (2011) D. Chakroborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multistage nanoparticle delivery system for deep penetration into tumor tissue
- (2011) C. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
- (2010) Sarbari Acharya et al. ADVANCED DRUG DELIVERY REVIEWS
- COX-2 and Prostaglandin EP3/EP4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL12-CXCR4 Chemokine Systems
- (2010) Hiroshi Katoh et al. AMERICAN JOURNAL OF PATHOLOGY
- Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
- (2010) D. G. Menter et al. CLINICAL CANCER RESEARCH
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung Cancer
- (2009) R. Mutter et al. CLINICAL CANCER RESEARCH
- Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization
- (2009) Zhang Wei et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
- (2008) J. M. Bailey et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation